Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone vs ropivacaine for epidural analgesia after lateral episiotomy
ChiCTR2500101509Phase 2Recruiting
- Sponsor
- Baotou Steel Third Hospital
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of hydromorphone in postoperative pain (2 arms), sponsored by Baotou Steel Third Hospital. Primary endpoint: Degree of pain (VAS score). Started Apr 2025; status: recruiting.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500101509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101509.